The North America Atrial Fibrillation Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
Heart palpitations, dizziness, lightheadedness, shortness of breath, and chest discomfort are examples of symptomatic episodes. Atrial fibrillation is linked to a higher risk of stroke, dementia, and heart failure. It belongs to the category of supraventricular tachycardia. The most frequent modifiable risk factors for AF a, re high blood pressure and valvular heart diseases.
Heart failure, cardiomyopathy, and congenital heart disease are other heart-related risk factors. Traumatic fever is frequently to blame for valvular heart disease in low- and middle-income nations. Risk factors for lung disease include COPD, obesity, and sleep apnea. Additional risk factors include thyrotoxicosis, diabetes mellitus, excessive alcohol use, and cigarette use.
However, none of the aforementioned dangers are present in around 50% of instances. After feeling the pulse, medical experts may suspect AF and confirm the diagnosis by analyzing an electrocardiogram (ECG). Regularly spaced QRS complexes without P waves are indicative of an AF ECG. Making healthy lifestyle adjustments including quitting smoking, increasing physical exercise, and cutting back on alcohol might minimize the likelihood of developing atrial fibrillation and lessen its effects if it does.
In the United States, heart disease remains the major cause of mortality for both sexes and members of the majority of racial and ethnic groups. Every 36 seconds, the cardiovascular disease takes one life in the USA. One in four fatalities in the US is caused by heart disease, which affects around 659,000 individuals annually. Between 2016 and 2017, the US spent roughly $363 billion on heart disease.
The US market dominated the North America Atrial Fibrillation Market by Country in 2021; thereby, achieving a market value of $677.3 million by 2028. The Canada market is experiencing a CAGR of 6.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.6% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Specialty Clinics, and Others. Based on Type, the market is segmented into Surgical and Non-Surgical. Based on Technology, the market is segmented into Radiofrequency, Laser, Cryotherapy, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Atrial Fibrillation Market is Estimated to reach $2.7 Billion by 2028, at a CAGR of 9.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, BIOTRONIK SE & Co. KG, Koninklijke Philips N.V., Siemens Healthineers AG (Siemens AG) and AtriCure, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospitals
- Specialty Clinics
- Others
By Type
By Technology
- Radiofrequency
- Laser
- Cryotherapy
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Abbott Laboratories
- Medtronic PLC
- BIOTRONIK SE & Co. KG
- Koninklijke Philips N.V.
- Siemens Healthineers AG (Siemens AG)
- AtriCure, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Atrial Fibrillation Market, by End User
1.4.2 North America Atrial Fibrillation Market, by Type
1.4.3 North America Atrial Fibrillation Market, by Technology
1.4.4 North America Atrial Fibrillation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
Chapter 4. North America Atrial Fibrillation Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Specialty Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Atrial Fibrillation Market by Type
5.1 North America Surgical Market by Country
5.2 North America Non-Surgical Market by Country
Chapter 6. North America Atrial Fibrillation Market by Technology
6.1 North America Radiofrequency Market by Country
6.2 North America Laser Market by Country
6.3 North America Cryotherapy Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Atrial Fibrillation Market by Country
7.1 US Atrial Fibrillation Market
7.1.1 US Atrial Fibrillation Market by End User
7.1.2 US Atrial Fibrillation Market by Type
7.1.3 US Atrial Fibrillation Market by Technology
7.2 Canada Atrial Fibrillation Market
7.2.1 Canada Atrial Fibrillation Market by End User
7.2.2 Canada Atrial Fibrillation Market by Type
7.2.3 Canada Atrial Fibrillation Market by Technology
7.3 Mexico Atrial Fibrillation Market
7.3.1 Mexico Atrial Fibrillation Market by End User
7.3.2 Mexico Atrial Fibrillation Market by Type
7.3.3 Mexico Atrial Fibrillation Market by Technology
7.4 Rest of North America Atrial Fibrillation Market
7.4.1 Rest of North America Atrial Fibrillation Market by End User
7.4.2 Rest of North America Atrial Fibrillation Market by Type
7.4.3 Rest of North America Atrial Fibrillation Market by Technology
Chapter 8. Company Profiles
8.1 Johnson & Johnson
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.2 MicroPort Scientific Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Approvals and Trials:
8.3 Medtronic PLC
8.3.1 Company overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.3.5.2 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Boston Scientific Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.5.2 Acquisition and Mergers:
8.4.5.3 Approvals and Trials:
8.4.6 SWOT Analysis
8.5 BIOTRONIK SE & Co. KG
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Approvals and Trials:
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.6.5.2 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.7.5.3 Geographical Expansions:
8.8 Siemens Healthineers AG (Siemens AG)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Product Launches and Product Expansions:
8.8.5.2 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 AtriCure, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Acquisition and Mergers:
8.9.5.3 Approvals and Trials:
TABLE 1 North America Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 2 North America Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Atrial Fibrillation Market
TABLE 4 Product Launches And Product Expansions – Atrial Fibrillation Market
TABLE 5 Acquisition and Mergers – Atrial Fibrillation Market
TABLE 6 Approvals and Trials – Atrial Fibrillation Market
TABLE 7 North America Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 8 North America Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 9 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Specialty Clinics Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Specialty Clinics Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 16 North America Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 17 North America Surgical Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Surgical Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Non-Surgical Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Non-Surgical Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 22 North America Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 23 North America Radiofrequency Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Radiofrequency Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Laser Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Laser Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Cryotherapy Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Cryotherapy Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Atrial Fibrillation Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Atrial Fibrillation Market by Country, 2022 - 2028, USD Million
TABLE 33 US Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 34 US Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 35 US Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 36 US Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 37 US Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 38 US Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 39 US Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 40 US Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 41 Canada Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 42 Canada Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 43 Canada Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 44 Canada Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 45 Canada Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 46 Canada Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 47 Canada Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 48 Canada Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 49 Mexico Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 50 Mexico Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 51 Mexico Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 52 Mexico Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 53 Mexico Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 54 Mexico Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 55 Mexico Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 56 Mexico Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 57 Rest of North America Atrial Fibrillation Market, 2018 - 2021, USD Million
TABLE 58 Rest of North America Atrial Fibrillation Market, 2022 - 2028, USD Million
TABLE 59 Rest of North America Atrial Fibrillation Market by End User, 2018 - 2021, USD Million
TABLE 60 Rest of North America Atrial Fibrillation Market by End User, 2022 - 2028, USD Million
TABLE 61 Rest of North America Atrial Fibrillation Market by Type, 2018 - 2021, USD Million
TABLE 62 Rest of North America Atrial Fibrillation Market by Type, 2022 - 2028, USD Million
TABLE 63 Rest of North America Atrial Fibrillation Market by Technology, 2018 - 2021, USD Million
TABLE 64 Rest of North America Atrial Fibrillation Market by Technology, 2022 - 2028, USD Million
TABLE 65 Key information – Johnson & Johnson
TABLE 66 key Information – MicroPort Scientific Corporation
TABLE 67 Key Information – Medtronic PLC
TABLE 68 key Information – Boston Scientific Corporation
TABLE 69 Key Information – BIOTRONIK SE & Co. KG
TABLE 70 Key Information – Abbott Laboratories
TABLE 71 Key Information – Koninklijke Philips N.V.
TABLE 72 Key Information – Siemens Healthineers AG
TABLE 73 Key Information – AtriCure, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2018, Jun – 2022, Jan) Leading Players
FIG 5 Recent strategies and developments: MicroPort Scientific Corporation
FIG 6 Swot analysis: Medtronic plc
FIG 7 Recent strategies and developments: Boston Scientific Corporation
FIG 8 SWOT Analysis: Boston Scientific Corporation
FIG 9 Swot analysis: Abbott laboratories
FIG 10 Recent strategies and developments: Koninklijke Philips N.V.
FIG 11 Recent strategies and developments: Siemens Healthineers AG
FIG 12 Swot analysis: Siemens AG
FIG 13 Recent strategies and developments: AtriCure, Inc.